BCRX - BioCryst Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

BCRX is currently covered by 12 analysts with an average price target of $10.21. This is a potential upside of $6 (142.52%) from yesterday's end of day stock price of $4.21.

BioCryst Pharmaceuticals's activity chart (see below) currently has 116 price targets and 108 ratings on display. The stock rating distribution of BCRX is 78.57% BUY and 21.43% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.49% with an average time for these price targets to be met of 358.86 days.

Highest price target for BCRX is $30, Lowest price target is $6, average price target is $10.21.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 08-Jan-2024. First documented stock forecast 18-Feb-2014.

Currently out of the existing stock ratings of BCRX, 22 are a BUY (78.57%), 6 are a HOLD (21.43%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

12

$7.79 (185.04%)

12

3 months 18 days ago

3/8 (37.5%)

$4.35 (56.86%)

348

Buy

14

$9.79 (232.54%)

16

3 months 18 days ago

4/9 (44.44%)

$6.35 (83.01%)

149

Buy

10

$5.79 (137.53%)

21

5 months 6 days ago

3/5 (60%)

$4.6 (85.19%)

232

Buy

10

$5.79 (137.53%)

11

5 months 23 days ago

4/6 (66.67%)

$3.96 (65.56%)

201

6

$1.79 (42.52%)

14

5 months 23 days ago

6/9 (66.67%)

$-0.04 (-0.66%)

42

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BCRX (BioCryst Pharmaceuticals) average time for price targets to be met?

On average it took 358.86 days on average for the stock forecasts to be realized with a an average price target met ratio 57.49

Which analyst has the current highest performing score on BCRX (BioCryst Pharmaceuticals) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on BCRX (BioCryst Pharmaceuticals)?

Andrew Fein has 15 price targets and 11 ratings on BCRX

Which analyst is the currently most bullish on BCRX (BioCryst Pharmaceuticals)?

Andrew Fein with highest potential upside - $25.79

Which analyst is the currently most reserved on BCRX (BioCryst Pharmaceuticals)?

Charles Duncan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?